Stay informed with the latest updates for the inheritable blood disorders community. Industry First Patient Dosed with Investigational Sub-Q Therapy for von…Mar 5, 2025 Industry Pfizer Discontinues Beqvez Hemophilia B Gene TherapyFeb 25, 2025 Medical FDA Approves New Non-Opioid Treatment for Pain Jan 31, 2025 Medical Clinical Practice and Hemophilia Gene Therapy the Focus of New…Jan 13, 2025 Industry Investigational Sub-Q Von Willebrand Disease Therapy Put on Fast TrackJan 10, 2025 Medical FDA Approves Subcutaneous Therapy for Hemophilia Patients with Inhibitors…Dec 23, 2024 Industry Trial Updates for Investigational Hemophilia A Gene Therapy Shared at ASH…Dec 13, 2024 Industry Sanofi Announces Positive Data for Its Investigational ITP TherapyDec 11, 2024 Industry Star Therapeutics Presents Data on Investigational VWD Therapy Dec 10, 2024 Medical Provide Your Feedback on the WFH Hemophilia Guidelines Today! Nov 25, 2024 Medical New Documents Cover Bleeding Disorders, Bone Health, Mental Health…Oct 30, 2024 Medical FDA Approves Pfizer's HYMPAVZI for Hemophilia A and B TreatmentOct 14, 2024 Medical Support Networks and Clinical Trials the Focus of Upcoming FDA WebinarOct 11, 2024 Medical CHOP Researchers Investigate Durability of Hemophilia A Gene TherapyOct 11, 2024 Medical Enduring Education Focuses on Hemophilia Non-Factor Replacement TherapyAug 30, 2024 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page